BACKGROUND: Numerous types of glucans have been isolated from almost every species of yeast, grain, and fungi. These products have been extensively studied for their immunological and pharmacological effects. AIM: In this paper we evaluated the possibility whether individual glucans will be similarly active against each of the tested biological properties or if each glucan will affect different reactions. METHODS: Immunological effects of glucans were measured by evaluation of phagocytosis of HEMA particles by peripheral blood leukocytes and production of IL-2 by mouse splenocytes. Next we measured the effects of long-term treatment with glucan on levels of blood glucose and blood cholesterol. Four different glucans differing in origin (yeast, grain and mushroom) were used. RESULTS: Our results showed that the same glucan, yeast-derived insoluble #300 glucan, stimulated phagocytosis of peripheral blood leukocytes, production of IL-2 by mouse splenocytes, lowered the cholesterol levels in mice with experimentally-induced cholesterolemia and lowered the level of blood sugar after induced hyperglycaemie. The remainder of tested glucans were only marginally active. CONCLUSION: Taken together, our study showed that with respect to natural glucans, there is a yes-or-no effect suggesting that highly purified and highly active glucans will have pleiotropic impact, whereas poorly isolated and/or less active glucans will have only mediocre biological properties.

University of Louisville Department of Pathology Louisville KY USA

Citace poskytuje Crossref.org

Cereal β-d-Glucans in Food Processing Applications and Nanotechnology Research

Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

β-glucans and cholesterol (Review)

Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity

Placebo-driven clinical trials of yeast-derived β-(1-3) glucan in children with chronic respiratory problems